Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Healthcare Diagnostics & Research Medical Instruments & Supplies

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

(352)
•••

Post by hmmmmmmmmon Sep 11, 2025 7:05pm

128 Views

Post# 36711642

Not sure

if folks are following the chat on the yahoo!finance page, it's not as lively, but thought this post was worth copying over.

"Up 244% YTD -while still completely under the radar. Amazing Tigris trial results released. And, the FDA has granted PMX "Breakthrough Device" designation.

In October once Spectral submits the final module of their PMA "Premarket Approval" -things will move quickly. Do not be surprised by a Vantive Carlyle Group buyout of PMX and EAA soon after."

<< Previous

Bullboard Posts

Next >>

Strengthening its position as Europe’s premier emerging tungsten player